MedTrace Logo

Texture Analysis for Postmenopausal Osteoporosis

NCT00145977 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2018-09-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if a new test for osteoporosis can be useful in monitoring treatment. We are studying a new method for examining the quality of bone by an experimental method of computerized analysis of radiographic images (x-ray pictures) of the heel.

Conditions

Interventions

DRUG

Alendronate

alendronate 70 mg once weekly

DIETARY_SUPPLEMENT

Calcium Citrate

600 mg of calcium citrate

DIETARY_SUPPLEMENT

Vitamin D

500 mg of Vitamin D consumed with the evening meal.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • University of Chicago

    lead OTHER

Principal Investigators

  • Tamara Vokes, MD · University of Chicago

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
59 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-07-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00145977 on ClinicalTrials.gov